DR Congo Ebola cases cross 5,500 with 2,642 deaths, WHO warns of 'defining moment'
Synopsis
The DRC's Ebola outbreak has become the fastest-growing in the country's history — 5,514 confirmed cases, 2,642 deaths, and a 47.9% fatality rate more than 100 days in. With 60% of recent deaths happening outside treatment centres and conflict blocking health teams across eastern DRC, the WHO's 'defining moment' warning is not rhetorical — it is a frank admission that control efforts are losing ground.
Key Takeaways
Confirmed Ebola cases in the DRC have reached 5,514 , with 2,642 deaths as of 24 August .
The case fatality rate stands at 47.9 per cent ; 1,200 patients have recovered.
The outbreak — caused by Bundibugyo ebolavirus — is the fastest-growing ever recorded in the DRC.
Ituri province accounts for 85 per cent of cases and 79 per cent of deaths.
Around 60 per cent of recent fatalities occurred outside Ebola treatment centres, signalling gaps in early detection.
Testing labs have grown from 1 to 19 ; treatment bed capacity has risen from fewer than 10 to over 1,300 .
Confirmed Ebola cases in the Democratic Republic of the Congo (DRC) have surpassed 5,500, with more than 2,600 deaths recorded, according to government figures released on Monday, 24 August. The World Health Organisation (WHO) declared the outbreak had reached a 'defining moment' — more than 100 days after it was first declared in May.
Scale of the Outbreak
The latest official tally, covering data through Saturday, recorded 5,514 confirmed cases and 2,642 deaths, placing the case fatality rate at 47.9 per cent. A total of 1,200 patients have recovered. The outbreak, caused by the Bundibugyo ebolavirus, has spread to 57 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, Bas-Uele, and Tshopo provinces.
The WHO has described this as the fastest-growing Ebola outbreak ever recorded in the DRC, warning that transmission continues to outpace control efforts.
What the WHO Said
WHO Regional Director for Africa Mohamed Janabi stated in an official release: 'This outbreak has reached a defining moment. The choices we make now will determine how quickly we can bring this outbreak under control, protect and save lives.'
WHO Director-General Tedros Adhanom Ghebreyesus called for sustained resources and stronger cooperation, saying: 'We can bring the Ebola outbreak under control but only through scaled-up action in affected communities.'
Epicentre and Key Concerns
Ituri province remains the epicentre, accounting for approximately 85 per cent of all cases and 79 per cent of deaths, according to the WHO. Deaths occurring outside Ebola treatment centres are a major concern — community deaths accounted for around 60 per cent of fatalities recorded in recent weeks, pointing to persistent problems with early detection, referral, and access to treatment.
The WHO identified insecurity, recurrent conflict, population displacement, attacks on health facilities, community reluctance, and difficult access as ongoing obstacles — particularly in eastern DRC.
Response Capacity and Medical Advances
Response capacity has expanded significantly since the outbreak began. The number of laboratories capable of testing for Ebola has risen from one to 19, with capacity to process more than 3,000 samples per day. Treatment capacity has grown from fewer than 10 beds to more than 1,300, according to the WHO.
Clinical trials of potential treatments and evaluations of candidate vaccines are underway. Notably, the first emergency-listed molecular diagnostic test for Bundibugyo virus disease has been deployed — a significant step in expanding diagnostic reach.
What Comes Next
The WHO warned that the coming months will be critical to closing remaining gaps and slowing transmission. The agency stressed that an end to armed conflict in affected areas is also essential for health teams to reach communities. Without a sustained and coordinated international response, officials caution, the outbreak's trajectory remains deeply uncertain.
Point of View
Yet the structural barriers — conflict, displacement, community distrust — remain as entrenched as ever. The WHO's 'defining moment' framing is accurate, but it also risks becoming a familiar refrain: international urgency that peaks at the press release and fades before resources materialise on the ground. The deployment of the first emergency-listed Bundibugyo diagnostic is a genuine advance, but diagnostic capacity means little when health workers cannot safely reach communities. The central question is not whether the world knows how to contain Ebola — it does — but whether the political will and security conditions will allow that knowledge to be applied.
NationPress
24 Aug 2026
Frequently Asked Questions
How many Ebola cases and deaths have been recorded in the DRC?
As of 24 August, the DRC has recorded 5,514 confirmed Ebola cases and 2,642 deaths, with a case fatality rate of 47.9 per cent. A total of 1,200 patients have recovered.
What is the Bundibugyo ebolavirus?
The Bundibugyo ebolavirus is one of several strains of the Ebola virus and is the cause of the current DRC outbreak declared in May. It is distinct from the more commonly known Zaire ebolavirus strain responsible for previous large outbreaks.
Why is the WHO calling this a 'defining moment'?
The WHO used the phrase to signal that the outbreak — now more than 100 days old and the fastest-growing ever in the DRC — has reached a stage where immediate, scaled-up action is critical. Officials warn that transmission is outpacing control efforts and that the coming months will determine the outbreak's trajectory.
Which areas of the DRC are worst affected?
Ituri province is the epicentre, accounting for about 85 per cent of all cases and 79 per cent of deaths. The outbreak has spread across 57 health zones in Ituri, North Kivu, South Kivu, Haut-Uele, Bas-Uele, and Tshopo provinces.
What is being done to contain the outbreak?
Response capacity has expanded significantly: testing laboratories have grown from 1 to 19, with capacity to process over 3,000 samples daily, and treatment bed capacity has risen from fewer than 10 to more than 1,300. Clinical trials of potential treatments and vaccine evaluations are also underway, and the first emergency-listed molecular diagnostic test for Bundibugyo virus disease has been deployed.
